TORRANCE, Calif., Sept. 3, 2019 /PRNewswire/ -- Emmaus Life Sciences, Inc. (Nasdaq: EMMA), a leader in sickle cell disease treatment, announced today the allowance of patent application number 12860587.0, directed to the treatment of diverticulosis, by the European Patent Office. The allowance of this application follows the issuance of corresponding patents in

NEW YORK, Sept. 3, 2019 /PRNewswire/ -- Oramed Pharmaceuticals Inc. (NASDAQ: ORMP) (TASE: ORMP) (www.oramed.com), a clinical-stage pharmaceutical company focused on the development of oral drug delivery systems, today announced that the company will present at three conferences in

BERLIN, Sept. 3, 2019 /PRNewswire/ -- Bayer today announced Marianne De Backer PhD as the new Head of Business Development & Licensing of its Pharmaceuticals Division. She will report to Stefan Oelrich, Member of the Board of Management, Bayer AG, and President of the company's Pharmaceuticals Division and join the Pharmaceuticals

SOUTH SAN FRANCISCO, Calif., Sept. 3, 2019 /PRNewswire/ -- Satsuma Pharmaceuticals, Inc. ("Satsuma" or "the Company"), a clinical-stage biopharmaceutical company developing STS101 (dihydroergotamine (DHE) nasal powder) for the acute treatment of migraine, today announced that it will be presenting two posters at the 19th Congress of the International Headache

SAN DIEGO, Sept. 3, 2019 /PRNewswire/ -- Trovagene, Inc. (Nasdaq: TROV), a clinical-stage, Precision Cancer Medicine™ oncology therapeutics company developing drugs that target cell division (mitosis) for the treatment of various cancers including prostate, colorectal and leukemia, today announced it will be presenting at the H.C. Wainwright 21

SAN DIEGO, Sept. 3, 2019 /PRNewswire/ -- Biocept, Inc. (NASDAQ: BIOC), a leading commercial provider of liquid biopsy tests designed to provide physicians with clinically actionable inform

BOSTON, Sept. 3, 2019 /PRNewswire/ -- The Society for Participatory Medicine (SPM), the preeminent organization in promoting true partnershi

PHOENIX, Sept. 3, 2019 /PRNewswire/ -- With every birthday comes a wish and EōS Fitness is marking its five-year birthday milestone with a wish to raise money for the Children's Cancer Rese

DALLAS, Sept. 3, 2019 /PRNewswire/ -- SWK Holdings Corporation (SWKH.OB) ("SWK" or the "Company"), a life science focused specialty finance company, announced today that the Company has submitted its formal application to list its common shares on the NASDAQ Capital Market. Concurrently, SWK announced the appointment of Winston Black

Safety Outcomes of Interest Observed in Less Than 1% Cases; Zero Deaths ReportedGreater Than 70% of Atrial Fibrillation Episodes Successfully Converted to Sinus Rhythm in a Median Time of 12 MinutesNASDAQ: CORV   TSX: CORV VANCOUVER, Sept. 3, 2019 /PRNewswire/ - Correvio Pharma Corp. (NASD